Resolvin D2 Reduces UVB Skin Pathology by Targeting Cytokines, Oxidative Stress, and NF-κB Activation

UVB skin pathology is initiated by reactive oxygen species (ROS), differentiating this condition from other inflammatory diseases involving first the immune cell activation by danger or pathogen molecular patterns followed by oxidative stress. Resolvin D2 (RvD2) has been found to reduce inflammation...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ingrid C. Pinto, Priscila Saito, Camilla C. A. Rodrigues, Renata M. Martinez, Cristina P. B. Melo, Maiara Piva, Clovis M. Kumagai, David L. Vale, Telma Saraiva-Santos, Allan J. C. Bussmann, Marcela M. Baracat, Sandra R. Georgetti, Fabiana T. M. C. Vicentini, Waldiceu A. Verri, Rubia Casagrande
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Series:	Antioxidants
Subjects:	pro-resolution lipid antioxidant UV radiation inflammation
Online Access:	https://www.mdpi.com/2076-3921/14/7/830
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Resolvin D2 Reduces UVB Skin Pathology by Targeting Cytokines, Oxidative Stress, and NF-κB Activation

Similar Items